TSH Monitoring in I-131 Treated Hyperthyroid Cats

x
By David Carabetta, DVM, DACVECC
angell.org/i131
i131@angell.org
617-522-7282
April 2025

x

xx

x

x

Navigating Post-Radioiodine Hypothyroidism in Feline Hyperthyroidism: The Role of TSH Monitoring

Feline hyperthyroidism, a common endocrinopathy in older cats, is frequently managed with radioactive iodine (RAI) therapy. While RAI is highly effective in resolving hyperthyroidism, it carries the risk of inducing hypothyroidism, a complication that can significantly impact feline health. Therefore, meticulous monitoring is essential, and thyroid-stimulating hormone (TSH) testing plays a pivotal role in detecting and managing this post-treatment complication.

Understanding the Post-RAI Thyroid Landscape

RAI works by selectively destroying hyperfunctioning thyroid follicular cells. While this effectively normalizes thyroid hormone levels, it can inadvertently ablate excessive thyroid tissue, leading to iatrogenic hypothyroidism. This consequence can manifest in various forms:

• Overt Hypothyroidism: Characterized by clinical signs like lethargy, weight gain, decreased appetite, and dermatological changes, along with a total thyroxine (tT4) below the reference range and elevated TSH.
• Subclinical Hypothyroidism: Defined by a tT4 that is within the lower end of the reference range, and TSH that is mildly elevated, suggesting a subtle decline in thyroid reserve.

The Clinical Utility of TSH Testing

TSH, secreted by the pituitary gland, acts as a sensitive indicator of thyroid function. In cats, its concentration is inversely related to tT4 levels. When tT4 decreases, TSH increases to stimulate thyroid hormone production. This feedback loop makes TSH a valuable tool for:

• Early Detection of Hypothyroidism: TSH elevation can precede a decrease in tT4, allowing for the identification of subclinical hypothyroidism before significant clinical signs emerge.
• Distinguishing Between Hypothyroidism and Euthyroid Sick Syndrome: In cats with non-thyroidal illnesses, tT4 may be suppressed, mimicking hypothyroidism. TSH measurement can help differentiate between true hypothyroidism, where TSH is elevated, and euthyroid sick syndrome, where TSH remains within the reference range.

Pre-RAI TSH Considerations

While tT4 and free T4 (fT4) are the primary diagnostic tools for hyperthyroidism, pre-RAI TSH is often suppressed in hyperthyroid cats and can be used to support an otherwise equivocal diagnosis of hyperthyroidism.  Detectable levels of TSH at the time of treatment are associated with an increased risk of hypothyroidism post-treatment. They may be a consideration in delaying RAI treatment for cats with mild hyperthyroidism.

Post-RAI Monitoring Protocol

A standardized post-RAI monitoring protocol is crucial for early detection and management of hypothyroidism. A suggested protocol includes:

• Initial Check (1 Month Post-RAI): Measure tT4, TSH, and renal values. This initial check helps confirm the response to RAI treatment and identify cats with overt or subclinical hypothyroidism.
• Intermediate Check (3 Months Post-RAI): Repeat T4, TSH, and renal values. Some cats that initially appear euthyroid could progress to hypothyroid. And some cats initially classified as hypothyroid will show a rebound in thyroid function.

Interpreting TSH Results and Clinical Implications

• Elevated TSH with Low tT4: Indicates overt hypothyroidism. Levothyroxine supplementation is warranted. If this is the initial 1-month post-RAI recheck and no clinical signs or azotemia are present, then delaying treatment and re-evaluation can be considered.
• Elevated TSH with Normal tT4: Suggests subclinical hypothyroidism. Close monitoring and potential levothyroxine supplementation may be considered, especially if clinical signs or new azotemia have developed.
• Normal TSH with Normal tT4: Indicates euthyroidism. Continued monitoring is recommended.
• Suppressed TSH with elevated tT4: Indicates persistent hyperthyroidism. Further treatment may be required.

Detecting Occult and Subclinical Hypothyroidism

The sensitivity of TSH in detecting subtle changes in thyroid function makes it a powerful tool for identifying occult and subclinical hypothyroidism. By monitoring TSH levels, veterinarians can identify cats with early thyroid dysfunction before they exhibit overt clinical signs. This proactive approach allows for timely intervention and prevents the development of more severe hypothyroidism.  Supplementation of levothyroxine can provide a survival benefit in some iatrogenic hypothyroid cats.

Benefits of Early Detection and Intervention

Early detection and intervention of post-RAI hypothyroidism offer several benefits:

• Improved Quality of Life: Early intervention enhances the cat’s overall well-being by preventing or minimizing clinical signs.
• Reduced Morbidity: Hypothyroidism can lead to various complications, including cardiac dysfunction and neurological abnormalities. Early treatment minimizes these risks.
• Enhanced Client Satisfaction: Proactive monitoring and management demonstrate a commitment to optimal patient care, fostering client trust.
• Preventative care: Catching issues before they become clinical allows for more effective treatment and less suffering for the cat.

Conclusion

TSH testing is an indispensable tool in the post-RAI management of feline hyperthyroidism. Its sensitivity and specificity make it highly effective in detecting overt and subclinical hypothyroidism. By incorporating TSH monitoring into a standardized post-RAI protocol, veterinarians can provide optimal care for their feline patients, ensuring their long-term health and well-being. Proactive monitoring, coupled with prompt intervention, allows for the successful management of RAI-induced hypothyroidism, ultimately improving the quality of life for cats with hyperthyroidism.

x

x

References

• Cox SE, Wakeling J, Hall T, Williams TL. Survival of radioiodine-treated hyperthyroid cats that are euthyroid and hypothyroid after treatment, and the effect of levothyroxine supplementation on the survival time of cats with iatrogenic hypothyroidism. J Vet Intern Med. 2025 Jan-Feb;39(1):e17295. doi: 10.1111/jvim.17295. PMID: 39831449; PMCID: PMC11744366.
• Peterson ME, Guterl JN, Nichols R, Rishniw M. Evaluation of Serum Thyroid-Stimulating Hormone Concentration as a Diagnostic Test for Hyperthyroidism in Cats. J Vet Intern Med. 2015 Sep-Oct;29(5):1327-34. doi: 10.1111/jvim.13585. Epub 2015 Jul 20. PMID: 26192742; PMCID: PMC4858046.
• Peterson ME, Rishniw M. Predicting outcomes in hyperthyroid cats treated with radioiodine. J Vet Intern Med. 2022 Jan;36(1):49-58. doi: 10.1111/jvim.16319. Epub 2021 Nov 24. PMID: 34817910; PMCID: PMC8783366.
• Fernandez Y, Puig J, Powell R, Seth M. Prevalence of iatrogenic hypothyroidism in hyperthyroid cats treated with radioiodine using an individualised scoring system. J Feline Med Surg. 2019 Dec;21(12):1149-1156. doi: 10.1177/1098612X18822396. Epub 2019 Jan 22. PMID: 30667287; PMCID: PMC10814268.
• Lucy JM, Peterson ME, Randolph JF, Scrivani PV, Rishniw M, Davignon DL, Thompson MS, Scarlett JM. Efficacy of Low-dose (2 millicurie) versus Standard-dose (4 millicurie) Radioiodine Treatment for Cats with Mild-to-Moderate Hyperthyroidism. J Vet Intern Med. 2017 Mar;31(2):326-334. doi: 10.1111/jvim.14646. Epub 2017 Feb 3. PMID: 28158908; PMCID: PMC5354058.